True Wealth Design’s aTyr Pharma ATYR Stock Holding History

True Wealth Design’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$92	Sell	301 -163	-35%	-$79	﹤0.01%	2453
2026 Q2	$277	Buy	464 +392	+544%	+$256	﹤0.01%	2374
2026 Q1	$57	Buy	+72	New	+$61	﹤0.01%	2555

Other funds holding ATYR

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design's ATYR Position: Q3 2026 in Review

True Wealth Design reduced its aTyr Pharma (ATYR) stake by 35% in Q3 2026, selling an estimated $79 and leaving 301 shares worth $92. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

True Wealth Design first reported a position in ATYR in Q1 2026 and has held it in 3 quarters since. The position peaked at $277 in Q2 2026. 4 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

True Wealth Design held 301 shares of aTyr Pharma worth $92 as of Q3 2026.
True Wealth Design sold 163 aTyr Pharma shares in Q3 2026, an estimated $79.
aTyr Pharma made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2453 holding.
True Wealth Design first reported a position in aTyr Pharma in Q1 2026 and has held it in 3 quarters since.
True Wealth Design's aTyr Pharma position peaked at $277 in Q2 2026.
4 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.